Mesentericin Y105 is a 37-residue bacteriocin produced by Leuconostoc mesenteroides Y105 that displays antagonistic activity against gram-positive bacteria such as Enterococcus faecalis and Listeria monocytogenes. It is closely related to leucocin A, an antimicrobial peptide containing -sheet and ␣-helical structures. To analyze structure-function relationships and the mode of action of this bacteriocin, we generated a collection of mesentericin derivatives. Mutations were obtained mostly by PCR random mutagenesis, and the peptides were produced by an original system of heterologous expression recently described (D. Morisset and J. Frère, Biochimie 84:569-576, 2002). Ten derivatives were obtained displaying modifications at eight different positions in the mesentericin Y105 sequence. Purified peptides were incorporated into lysophosphatidylcholine micelles and analyzed by circular dichroism. The ␣-helical contents of these peptides were compared and related to their respective bactericidal activities. Moreover, studies of the intrinsic fluorescence of tryptophan residues naturally occurring at positions 18 and 37 revealed information about insertion of the peptides in micelles. A model for the mode of action of mesentericin Y105 and related bacteriocins is proposed.Bacteriocins are proteinaceous compounds produced by many lactic acid bacteria. They generally display a narrow spectrum of antibacterial activity against species closely related to the producing strain. They have been classified on the basis of their biochemical characteristics (29,36). Class I peptides are the lantibiotics, which are small posttranslationally modified peptides that contain unusual amino acid derivatives such as lanthionine. The thermoresistant class II bacteriocins are further subdivided into three classes, namely, IIa (anti-Listeria peptides), IIb (two-component peptides), and IIc (sec-dependent bacteriocins). Class III bacteriocins are thermosensitive proteins. The fourth class, composed of complex molecules, has been disputed (45) and is currently disregarded. Among the class IIa bacteriocins, also known as pediocin-like bacteriocins, at least 24 anti-Listeria peptides were described previously (1, 3, 4, 9, 10, 16, 17, 20, 24, 26, 30-33, 39, 40, 46, 51, 53, 54, 56, 57, 60). These compounds share a YGNGVxCxxxxC consensus and a conserved disulfide bond within the N-terminal part of the peptide; they tend to differ mainly in their C-terminal domains (15). It is commonly accepted that these peptides exert bactericidal activity by forming pores in target cell membranes (9). Class IIa bacteriocins are mostly secreted from their producing cell by dedicated ATP-binding cassette (ABC) transporters and their accessory proteins, with concomitant cleavage of their N-terminal leader sequence (25, 29).However, some of these bacteriocins are exported by the general secretory pathway (sec) with cleavage of their N-terminal signal peptide (10, 32).Mesentericin Y105 (MesY105) is a 37-amino-acid class IIa bacteriocin produced by Leuconostoc mesen...